Central Pacific Bank Trust Division Neurocrine Biosciences Inc Transaction History
Central Pacific Bank Trust Division
- $723 Billion
- Q1 2025
A detailed history of Central Pacific Bank Trust Division transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 1,625 shares of NBIX stock, worth $208,292. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,625
Previous 3,702
56.1%
Holding current value
$208,292
Previous $505 Million
64.43%
% of portfolio
0.02%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.6MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.82 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.27 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$709 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$623 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$342 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...